Close X
Attorney Spotlight

Find out which two countries Cheryl Palmeri gets the most questions about related to International Trade in today's market? Find out more>


Close X


Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

John Kelly and Danielle Sloane Provide Insight on Fraud and Abuse and Compliance Issues for Clinical Labs

G2 Compliance Advisor

Media Mentions

February 5, 2016

Bass, Berry & Sims attorneys John Kelly and Danielle Sloane provided insight for two separate articles in the January 2016 issue of G2 Compliance Advisor, a monthly publication targeting issues associated with clinical labs and diagnostics practices. In the article, "Four Fraud and Abuse Enforcement Trends That Labs Should Be Aware Of," John cautioned, "'[e]nforcement is increasing. Efforts in health care fraud and abuse are picking up.'" 

Danielle provided commentary for several of the tips included in the article, "Top 10 Compliance Issues and Tips for 2016." According to the article, the top compliance issue facing labs this year will be medical necessity. As Danielle explains, "'[l]aboratories are going to increasingly have to justify the medical necessity of their tests, particularly testing that is done with any frequency ... laboratories may consider requesting submission of supporting medical records along with the test requisition to ensure the medical necessity support is there on the front end.'"

The full articles, "Four Fraud and Abuse Enforcement Trends That Labs Should Be Aware Of" and "Top 10 Compliance Issues and Tips for 2016," were published in the January 2016 issue of G2 Compliance Advisor (subscription required).

In Case You Missed It:

Related Professionals

Related Services


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.